EUVIMEDEUVIMED entdecken
Crossref

High-entropy nanozymes integrated with CRISPR/Cas12a cascade amplification for highly sensitive point-of-care detection of cardiac troponin I

Fanghua Liu, Lin Yang, Jun Zhang, Yin Wang, Fujian Xu, Yongjian Ai, Xue Jiang

Biosensors and Bioelectronics · 2026-12 · 313 · 119129

DOI: 10.1016/j.bios.2026.119129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-12. Verfasst von Fanghua Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, Key Laboratory of Land Resources Evaluation and Monitoring in Southwest, Ministry of Education, Sichuan N…. Hauptthemen laut MEDLINE: Troponin I, Biosensing Techniques, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction necessitates rapid and ultrasensitive point-of-care detection of cardiac troponin I (cTnI). In this work, we develop a HEAzyme-enabled interfacial electrocatalytic transduction strategy integrated with CHA-CRISPR/Cas12a amplification framework for ultrasensitive electrochemical detection of cTnI. Capitalizing on the cocktail effect and carbon-shell confinement, HEAzyme amplifies the electrochemical response by catalyzing the redox reaction of surface-confined methylene blue. Target recognition initiates CHA, generating abundant DNA activators for Cas12a trans-cleavage. The synergistic integration of molecular cascade amplification and interfacial electrocatalysis enables a limit of detection of 0.21 fg/mL across a broad linear range from 1 fg/mL to 100 pg/mL. It exhibits good selectivity, maintains good stability within 7 days (RSD = 3.9%), and shows good batch-to-batch reproducibility in different batches (RSD = 3.44 and 5.8% for intra and inter-batch, respectively). This work establishes an effective strategy for integrating CRISPR-based molecular amplification with HEAzyme-enabled interfacial electrocatalytic transduction, providing a promising electrochemical platform for point-of-care diagnosis of myocardial infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin IBiosensing TechniquesMyocardial InfarctionElectrochemical TechniquesPoint-of-Care SystemsCRISPR-Cas SystemsHumansLimit of DetectionNucleic Acid Amplification TechniquesReproducibility of ResultsBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Stichwörter der Autor:innen

CRISPRCardiac troponin ICatalytic hairpin assemblyElectrochemical biosensingHigh entropy nanozymes

Substanzen

Troponin ICas12a proteinBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Autor:innen und Institutionen

  • College of Chemistry and Materials Science, Key Laboratory of Land Resources Evaluation and Monitoring in Southwest, Ministry of Education, Sichuan Normal University, Chengdu, 610068, China.
  • School of Chemistry and Environment, Southwest Minzu University, Chengdu, 610041, China.
  • Food Laboratory of Zhongyuan, MOE Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing, 100193, China. Electronic address: ayj@cau.edu.cn.
  • College of Chemistry and Materials Science, Key Laboratory of Land Resources Evaluation and Monitoring in Southwest, Ministry of Education, Sichuan Normal University, Chengdu, 610068, China. Electronic address: jiangxue…

Förderung

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • National Key Research and Development Program of China
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Sichuan Normal University
  • Chinese Academy of Medical Sciences

Zitieren

APA

Liu, F., Yang, L., Zhang, J., Wang, Y., Xu, F., Ai, Y., & Jiang, X. (2026). High-entropy nanozymes integrated with CRISPR/Cas12a cascade amplification for highly sensitive point-of-care detection of cardiac troponin I. Biosensors and Bioelectronics, 313, 119129. https://doi.org/10.1016/j.bios.2026.119129

Vancouver

Liu F, Yang L, Zhang J, Wang Y, Xu F, Ai Y, et al. High-entropy nanozymes integrated with CRISPR/Cas12a cascade amplification for highly sensitive point-of-care detection of cardiac troponin I. Biosensors and Bioelectronics. 2026;313:119129. doi:10.1016/j.bios.2026.119129

BibTeX
@article{Liu2026,
  author = {Liu, Fanghua and Yang, Lin and Zhang, Jun and Wang, Yin and Xu, Fujian and Ai, Yongjian and Jiang, Xue},
  title = {High-entropy nanozymes integrated with CRISPR/Cas12a cascade amplification for highly sensitive point-of-care detection of cardiac troponin I},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {313},
  pages = {119129},
  doi = {10.1016/j.bios.2026.119129}
}
Kostenlos starten →